Callio Therapeutics Appoints Zachary Hornby As CEO
Veteran biotech executive to lead company growth as it advances multiple dual-payload ADCs through clinical development for people living with cancerPiers Ingram, PhD, Co-Founder, transitions to Senior Advisor and
Callio hired a new leader (Zachary Hornby) who has lots of experience in biotech—a company that makes medicine. This is like when a sports team gets a new coach to help them win; it shows the company is ready to grow.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.